Natural Resolution Rate of Bacterial Sinusitis Without Antibiotics
Approximately 80-86% of adults with acute bacterial rhinosinusitis (ABRS) will recover without antibiotic treatment within 7-15 days. 1, 2
Key Evidence on Spontaneous Resolution
The most robust data comes from multiple systematic reviews of randomized controlled trials comparing antibiotics to placebo in clinically diagnosed ABRS:
Cure or improvement rates at 7-15 days:
Number needed to treat: 10-18 patients must receive antibiotics for just one additional person to benefit beyond natural recovery 1, 3
Number needed to harm: Only 8 patients need antibiotics for one person to experience adverse effects—meaning antibiotics cause more harm than benefit in most cases 3
Clinical Implications
Watchful waiting is now a recommended first-line strategy for uncomplicated ABRS, not merely an option 1, 4, 5. This represents a significant shift from older approaches that emphasized immediate antibiotic prescribing.
When Watchful Waiting is Appropriate:
- Patients with uncomplicated ABRS regardless of symptom severity
- Reliable follow-up can be ensured
- No immune deficiency or complicated sinusitis
- Duration: up to 7 days after diagnosis 1, 4
When to Start Antibiotics:
Reserve antibiotics for patients with:
- Persistent symptoms >10 days without improvement
- Severe symptoms: fever >39°C (102°F) with purulent discharge and facial pain for ≥3 consecutive days
- "Double sickening": worsening after initial improvement following a typical viral illness 3
Important Caveats
The high spontaneous resolution rate applies specifically to uncomplicated ABRS in otherwise healthy adults. The evidence quality is Grade A, based on multiple systematic reviews of RCTs, though with some heterogeneity in diagnostic criteria 1, 2.
Common pitfall: Clinicians often prescribe antibiotics based on symptom duration alone (7-10 days), but this timeframe overlaps substantially with natural viral resolution. The key is distinguishing true bacterial infection using the specific criteria above, not just symptom duration 3.
Duration of illness is similar whether or not antibiotics are used, and complications occur at similar rates regardless of initial management 2. This reinforces that withholding antibiotics in appropriate cases does not increase risk.
The 2016 ACP/CDC guidelines emphasize that acute uncomplicated rhinosinusitis is self-limited even in patients with a bacterial cause 3, making shared decision-making essential when discussing the minimal benefits versus real harms of antibiotic therapy.